SEC Form 4 · accession 0001140361-15-010547
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Officer — VP, Corporate Controller
Period of report
Jun 4, 2014
Accepted (ET)
Mar 5, 2015 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 4, 2014 | A | 4,000 | $0.00 | A | 8,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF1,F3 | $63.10 | Jun 4, 2014 | A | 10,000 | A | Dec 4, 2014 | Jun 3, 2024 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The transaction is being reported on a delinquent basis due to an administrative oversight.
- F2Restricted stock units granted on June 4, 2014. Price not applicable.
- F3Option grant vests 6/48ths on December 4, 2014, and 1/48th on the 4th of every month thereafter.